Correction

Posted on April 14, 2021 by Gastroenterology

Noureddin M, Jones C, Alkhouri N, et al. Screening for nonalcoholic fatty liver disease in persons with type 2 diabetes in the United States is cost-effective: a comprehensive cost-utility analysis. Gastroenterology 2020;159:1985-1987.e4.

This entry was posted in News. Bookmark the permalink.